Milwaukee, WI, United States of America

James M Cook

USPTO Granted Patents = 51 

 

 

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 150(Granted Patents)

Forward Citations (Not Self Cited) = 108(Oct 12, 2025)


Location History:

  • Tucson, AZ (US) (2010 - 2014)
  • Whitefish Bay, WI (US) (2006 - 2019)
  • Milwaukee, WI (US) (2010 - 2024)
  • Houston, TX (US) (2019 - 2024)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
51 patents (USPTO):

Title: James M Cook: A Pioneering Inventor and Researcher in the Field of GABA(a) Receptor Modulators

Introduction:

In the realm of pharmaceutical innovations, inventors like James M Cook stand out for their groundbreaking contributions to medical science. With a portfolio of 20 patents and a focus on GABA(a) receptor modulators, Cook's research has paved the way for novel treatments in neuropsychiatric disorders, airway hyperresponsiveness in asthma, and various other medical conditions. This article explores the accomplishments and career milestones of this exceptional inventor.

Career and Patents:

James M Cook's journey as an inventor has included significant collaborations and affiliations with renowned organizations, such as the UWM Research Foundation, Inc. and the Centre for Addiction and Mental Health. Through these partnerships, Cook's research has led to the development and patenting of several innovative compounds.

One of Cook's latest patents involves substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators, specifically targeting alpha-4 and alpha-5 GABA receptors. These compounds offer promising potential in treating airway hyperresponsiveness and inflammation in asthma, while also demonstrating a preferable peripheral compartment effect and reduced central nervous system impact.

Furthermore, Cook's research has extended to ligands selective to alpha 6 subunit-containing GABAA receptors. The patented pyrazoloquinolinone compounds derived from this research may hold potential in treating a range of disorders with sensorimotor gating deficits, including schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and more.

Collaborations and Colleagues:

Throughout his career, James M Cook has collaborated with esteemed colleagues who have contributed to the success of his research. Among them, Wenyuan Yin and David A Baker stand out as valuable partners in their joint pursuit of advancements in the field of GABA receptor modulation.

Conclusion:

James M Cook has proven himself to be an outstanding inventor and researcher in the domain of GABA(a) receptor modulators. His patents, particularly in substituted benzo[f]imidazo[1,5-a][1,4]diazepines and ligands selective to alpha 6 subunit-containing GABAA receptors, offer hope for patients suffering from a variety of neuropsychiatric disorders and respiratory conditions like asthma. With ongoing research and innovation, the medical landscape continues to evolve, thanks to visionary inventors like James M Cook.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…